YC
NEO icon

Yarbrough Capital’s NeoGenomics NEO Stock Holding History

Yarbrough Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,572
Closed -$299K – 207
2024
Q2 		$299K Hold
21,572
– – 0.01% 171
2024
Q1 		$339K Hold
21,572
– – 0.01% 173
2023
Q4 		$349K Hold
21,572
– – 0.02% 172
2023
Q3 		$265K Hold
21,572
– – 0.02% 187
2023
Q2 		$347K Hold
21,572
– – 0.02% 167
2023
Q1 		$376K Buy
+21,572
New +$307K 0.03% 159

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Yarbrough Capital's NEO Position: Q3 2024 in Review

Yarbrough Capital sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 21,572 shares — an estimated $299K sold.

Yarbrough Capital first reported a position in NEO in Q1 2023 and held it in 6 quarters. The position peaked at $376K in Q1 2023. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Yarbrough Capital reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • Yarbrough Capital sold 21,572 NeoGenomics shares in Q3 2024, an estimated $299K.
  • Yarbrough Capital first reported a position in NeoGenomics in Q1 2023 and held it in 6 quarters.
  • Yarbrough Capital's NeoGenomics position peaked at $376K in Q1 2023.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Yarbrough Capital's 13F filing for Q3 2024, filed 15 Oct 2024.